Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Evaluation of renal artery in hypertensive patients by unenhanced MR angiography using spatial labeling with multiple inversion pulses sequence and by CT angiography.

OBJECTIVE: The purposes of this study were to determine the performance of a new unenhanced MR angiography (MRA) sequence, spatial labeling with multiple inversion pulses (SLEEK), with regard to its ability to present the renal arteries and to reveal renal artery disease in patients with secondary hypertension.

SUBJECTS AND METHODS: Unenhanced MRA using SLEEK was performed on a 1.5-T MRI system for assessing renal arteries in 50 patients with hypertension. Then all patients underwent CT angiography (CTA) within 1-7 days. The ability to present the renal arteries and to reveal renal artery disease with SLEEK was evaluated by two experienced radiologists and was compared with CTA results using a joint reading performed in consensus.

RESULTS: Forty-six patients with hypertension successfully underwent SLEEK MRA. A total of 119 renal arteries were assessed, including 86 normal arteries, 26 with stenoses, and seven with fibromuscular dysplasia on CTA. There was excellent correlation between SLEEK and CTA in presenting the degree of renal artery stenosis (r(s) = 0.851; p < 0.05). SLEEK was superior to CTA in revealing the third- and fourth-order segmental branches in the renal parenchyma (p < 0.05). SLEEK has the advantage of avoiding interference from vertebra, atherosclerotic plaques, and early venous system enhancement.

CONCLUSION: Unenhanced MRA using SLEEK is a reliable diagnostic method for evaluating renal artery disease and revealing segmental branches in the renal parenchyma. It is relatively inexpensive and is not associated with renal complications. It can be used as an alternative to CTA for screening for renal artery disease, especially in patients with hypertension and renal insufficiency.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app